Impact of breast cancer treatment guidelines on surgeon practice patterns: Results of a hospital-based intervention

Surgery

Volumn 128, Issue 5, 2000, Pages 847-861

  Mor, Vincent ^a,b,c,d   Laliberte, Linda L ^a,b,c,d   Petrisek, Ann C ^a,b,c,d   Intrator, Orna ^a,b,c,d   Wachtel, Tom ^a,b,c,d   Maddock, Phillip G ^a,b,c,d   Bland, Kirby I ^a,b,c,d  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c Kent Hospital   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; FEMALE; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; PARTIAL MASTECTOMY; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; UNITED STATES;

EID: 0033764560     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2000.109530     Document Type: Article

References (60)

1. Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women
2. The effect of age on treatment choice and survival in elderly breast cancer patients
3. Age as a predictor of diagnostic and initial treatment intensity in newly diagnosed breast cancer patients
4. Relationship between age at diagnosis and treatments received by cancer patients
5. Younger women with breast cancer have poorer prognosis than older women
6. The effect of less than definitive care on breast cancer recurrence and mortality
7. The treatment decision-making process: Age differences in a sample of women recently diagnosed with nonrecurrent, early-stage breast cancer
8. Factors associated with surgical and radiation therapy for early stage breast cancer in older women
9. The impact of age, marital status, and surgeon-patient interactions on the care of older women with breast carcinoma
10. Variations in breast conservation surgery for women with axillary lymph node negative breast cancer in British Columbia
11. Effects of the National Institutes of Health Consensus Development Program on Surgeon Practice
12. Changing practice patterns in the management of primary breast cancer: Consensus Development Program
13. Influencing surgeon prescribing through academic detailing with benchmarks
14. Principles of educational outreach ('academic detailing') to improve clinical decision making
15. Evaluating the message: The relationship between compliance rate and the subject of a practice guideline
16. Effect of clinical guidelines on medical practice: A systematic review of rigorous evaluations
17. Do practice guidelines guide practice? The effect of a consensus statement on the practice of surgeons
18. Effect of local medical opinion leaders on quality of care for acute myocardial infarction
19. Strategies to improve diabetes care delivery
20. The role of regulation in quality improvement
21. Assessing the impact of continuous quality improvement on clinical practice: What it will take to accelerate progress
22. Treatment of early stage breast cancer
23. Health Adjuvant chemotherapy for breast cancer
24. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
25. Current status of adjuvant systemic therapy for primary breast cancer: Progress and controversy
26. Systemic treatment of early stage breast cancer by hormonal, cytoxic or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women
27. Recent developments in the use of systemic adjuvant therapy for the treatment of breast cancer
28. Comparison of interview-based and medical-record based indices of comorbidity among breast cancer patients
29. Improved approximations for multilevel models with binary responses
30. Age-related differences in breast cancer treatment
31. Age-related patterns of care: Evidence against ageism in the treatment of early-stage breast cancer
32. The quality of care for treatment of early stage breast carcinoma: Is it consistent with national guidelines
33. Tumour excision plus continuous tamoxifen compared with modified radical mastectomy in patients over 70 years of age with operable breast cancer
34. Tamoxifen in breast conservation therapy
35. Tamoxifen with and without radiation after partial mastectomy in patients with involved nodes
36. Treatment of breast cancer in elderly patients
37. Tamoxifen or surgery plus tamoxifen as primary treatment for elderly patients with operable breast cancer
38. A retrospective study of tamoxifen and endometrial cancer in breast cancer patients
39. Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14
40. Volume-outcome relationships and in-hospital mortality - The effect of changes in volume over time
41. Coronary-artery bypass-surgery - The relationship between in-hospital mortality-rate and surgical volume after controlling for clinical risk-factors
42. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
43. Treatment of breast cancer
44. United States Abridged Life Tables, 1996
45. Determinants of survival in older cancer patients
46. Five versus more than five years of tamoxifen therapy for breast cancer patients with legative lymph nodes and estrogen receptor-positive tumors
47. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor positive tumors
48. Adherence to oral tamoxifen: A comparison of patient self-report, pill counts, and microelectronic monitoring
49. Palliative therapy in advanced ovarian cancer: Balancing patient expectations, quality of life and cost
50. Quality of life assessment and clinical decision-making
51. Predictors of medication adherence in the elderly
52. Predictors of medication noncompliance in a sample of older adults
53. Determinants of cancer therapy in elderly patients
54. Communication between surgeons and patients in routine office visits
55. Radiotherapy in the elderly
56. Tamoxifen in the treatment of breast cancer
57. Primary breast cancer in the elderly
58. The effect of age and comorbidity in the treatment of elderly women with nonmetastatic breast cancer